{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:49Z","timestamp":1788415969374,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The gut microbiota\u2013enteroendocrine axis contributes to the regulation of host energy homeostasis through microbial metabolites and satiety-related signaling. This study evaluated whether\n                      <jats:italic>Lactiplantibacillus pentosus<\/jats:italic>\n                      CECT 8039 (\n                      <jats:italic>L. pentosus<\/jats:italic>\n                      BB) modulates microbial fermentation, enteroendocrine responses, and metabolic and immune parameters associated with early diet-induced obesity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A dynamic multi-compartment colonic fermentation model was used to assess changes in cultivable microbial groups and short-chain fatty acid (SCFA) concentrations following probiotic treatment. Fermentation samples were subsequently evaluated in STC-1 enteroendocrine cells and a Caco-2\/THP-1 co-culture model. In parallel, the metabolic and immunomodulatory effects of\n                      <jats:italic>L. pentosus<\/jats:italic>\n                      BB were assessed in mice fed a high-fat diet (HFD) for 28 days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Probiotic treatment selectively modulated cultivable microbial groups, increasing lactic acid bacteria and decreasing\n                      <jats:italic>Clostridium<\/jats:italic>\n                      spp. across the three simulated colonic compartments, while other groups showed region-dependent changes. Acetate, propionate, and butyrate concentrations increased in all three compartments; in the ascending colon, they increased 2.53-, 7.34-, and 5.08-fold, respectively, relative to the end of stabilization. Fermentation samples collected after probiotic treatment increased GLP-1 release, reaching statistical significance in the transverse-colon condition, while\n                      <jats:italic>Pyy<\/jats:italic>\n                      mRNA expression increased significantly in the ascending and descending colon conditions and\n                      <jats:italic>Cck<\/jats:italic>\n                      expression increased significantly in all three compartments.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , HFD-fed mice showed a 34.9 \u00b1 5.5% body-weight gain, whereas probiotic supplementation was associated with a 13.2 \u00b1 4.7% lower relative body-weight gain compared with the HFD control group. In HFD-fed mice, probiotic supplementation reduced circulating resistin by 25.8 \u00b1 9.4% and leptin by 85.5 \u00b1 20.1%, whereas the change in adiponectin was not statistically significant. Immune responses were heterogeneous and depended on the experimental context.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>L. pentosus<\/jats:italic>\n                      BB was associated with increased colonic SCFA concentrations, enhanced enteroendocrine responses, and partial attenuation of HFD-associated metabolic alterations. These findings support a functional association between probiotic-modulated microbial fermentation and host endocrine and metabolic responses, although direct SCFA-mediated causality remains to be established.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1882392","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:23Z","timestamp":1788412583000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbial metabolite\u2013mediated modulation of enteroendocrine and immune pathways by Lactiplantibacillus pentosus CECT 8039 in early diet-induced obesity"],"prefix":"10.3389","volume":"17","author":[{"given":"Carmen","family":"Veciana-Galindo","sequence":"first","affiliation":[{"name":"Biopartner SL","place":["Alcoy, Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"N\u00fa\u00f1ez-Delegido","sequence":"additional","affiliation":[{"name":"Research and Development Department, Bioithas SL","place":["Alicante, Alicante, Spain"]},{"name":"Human Microbiota Research Group, Universidad Cat\u00f3lica de Murcia (UCAM)","place":["Guadalupe, Murcia, Spain"]},{"name":"Health Sciences PhD Program, Universidad Cat\u00f3lica de Murcia (UCAM)","place":["Guadalupe, Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gonz\u00e1lez-Santos","sequence":"additional","affiliation":[{"name":"Research and Development Department, Bioithas SL","place":["Alicante, Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ag\u00fcera-Santos","sequence":"additional","affiliation":[{"name":"Research and Development Department, Bioithas SL","place":["Alicante, Alicante, Spain"]},{"name":"Human Microbiota Research Group, Universidad Cat\u00f3lica de Murcia (UCAM)","place":["Guadalupe, Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Navarro-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Research and Development Department, Bioithas SL","place":["Alicante, Alicante, Spain"]},{"name":"Human Microbiota Research Group, Universidad Cat\u00f3lica de Murcia (UCAM)","place":["Guadalupe, Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Alberola-Jord\u00e1","sequence":"additional","affiliation":[{"name":"Biopartner SL","place":["Alcoy, Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2024.171216","article-title":"Incretin hormones, obesity and gut microbiota","volume":"178","author":"Angelini","year":"2024","journal-title":"Peptides"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2021.100332","article-title":"Role of enteroendocrine hormones in appetite and glycemia","volume":"23","author":"Ricardo-Silgado","year":"2021","journal-title":"Obes Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12263-021-00703-6","article-title":"Gut microbiota in patients with obesity and metabolic disorders - a systematic review","volume":"17","author":"Xu","year":"2022","journal-title":"Genes Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/s41467-023-38778-x","article-title":"Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial","volume":"14","author":"Corbin","year":"2023","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11906-020-01125-2","article-title":"Gut microbiota-derived short-chain fatty acids facilitate microbiota\u2013host cross-talk and modulate obesity and hypertension","volume":"23","author":"Overby","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01183-w","article-title":"Gut microbiota-derived short-chain fatty acids and their role in human health and disease","volume":"23","author":"Mukhopadhya","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kope\u0107","year":"2020","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00228615","article-title":"Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem","volume":"39","author":"Molly","year":"1993","journal-title":"Appl Microbiol Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/08910609409141354","article-title":"Validation of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) reactor using microorganism-associated activities","volume":"7","author":"Molly","year":"1994","journal-title":"Microb Ecol Health Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s13668-018-0248-8","article-title":"Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health","volume":"7","author":"Chambers","year":"2018","journal-title":"Curr Nutr Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate GLP-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2014.153","article-title":"The short-chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents","volume":"39","author":"Psichas","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2016.10.011","article-title":"Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety","volume":"6","author":"Brooks","year":"2017","journal-title":"Mol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.08.002","article-title":"Obesity and leptin resistance: distinguishing cause from effect","volume":"2","author":"Myers","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12626","article-title":"Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Borgeraas","year":"2018","journal-title":"Obes Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030635","article-title":"The role of probiotics and prebiotics in the prevention and treatment of obesity","volume":"11","author":"Cerd\u00f3","year":"2019","journal-title":"Nutrients"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2012.05.007","article-title":"Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals","volume":"53","author":"Million","year":"2012","journal-title":"Microb Pathog"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0386-0","article-title":"Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches","volume":"52","author":"Min","year":"2020","journal-title":"Exp Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S0007114516004037","article-title":"Can probiotics modulate human disease by impacting intestinal barrier function","volume":"117","author":"Bron","year":"2017","journal-title":"Br J Nutr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1882392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:23Z","timestamp":1788412583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1882392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":28,"alternative-id":["10.3389\/fendo.2026.1882392"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1882392","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1882392"}}